Drug intelligence / Profile preview

DAS869

Development stage: Unknown
Modality: Small Molecules

Overview

DAS869 is a small molecule compound classified as a benzoylpyrazole, an aromatic organic compound containing a benzoyl group attached to a pyrazole ring. Its chemical formula is C23H26N2O5S. While detailed pharmacological data and clinical indications are not publicly available, it is recognized as a research compound of interest in pharmacology and medicinal chemistry[1][2][3]. No information on its mechanism of action, therapeutic use, or clinical development status has been published in the major drug databases.

Beyond the preview

Go deeper on DAS869.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DAS869.

Explore the full profile